Home Vicebio

Vicebio

acquired
Series B
Developer of New Vaccines

Basic Information

Vicebio is a biopharmaceutical company. Vicebio is developing novel vaccines designed to provide first-class efficacy and ready-to-use, all-liquid formulations. Its unique molecular clamp technology locks viral surface proteins into their optimal conformation to achieve high immunogenicity and stability.
Vicebio Ltd
London,England,United Kingdom
unclear
January 01, 2019
info@vicebio.com